Investors were obviously impressed with the company's latest acquisition. Well before market open, Bausch announced that its Solta Medical aesthetics unit closed a deal to acquire China's Wuhan Shibo ...

On a down Monday for the stock market, Bausch Health Companies (NYSE: BHC) shares rose at a double-digit rate. Investors, cheered by news of a fresh company acquisition, pushed its stock price up by ...

In recent days, Bausch Health Companies launched an offer to exchange up to US$1.6 billion of its 4.875% and 11.00% Senior Secured Notes due 2028 for new 10.00% Senior Secured Notes due 2032, with ...

Bausch Health (BHC) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

The latest update is out from Bausch + Lomb Corporation ( (BLCO)). On November 13, 2025, Bausch + Lomb Corporation announced its plans during an Investor Day event at the New York Stock Exchange, ...

VAUGHAN, Ontario, November 13, 2025--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will ...

Bausch Health shares jumped after reporting a profit in the third quarter as its gastroenterology and medical devices segments supported strong revenue growth. Shares trading in Toronto rose 11% to ...

Bausch + Lomb (NYSE:BLCO) announced Q3 2025 earnings and revenue that topped expectations, supported by growth across its business segments. The company also raised portions of its full-year outlook, ...

(a) The impact for changes in foreign currency exchange rates is determined as the difference in the current period reported revenues at their current period currency exchange rates and the current ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

If you have been eyeing Bausch + Lomb stock and wondering whether now is the moment to make your move, you are not alone. It is not every day you see a company with such a recognizable name and a ...

Shares of eyecare company Bausch + Lomb (NYSE:BLCO) jumped 3.1% in the morning session after reports revealed an activist investor, Jana Partners, took a stake in competitor Cooper Companies and was ...